The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Provepharm’s strategy first bore fruit with the development of a new and patented method for synthesizing methylene blue. This new active ingredient enabled the company to obtain marketing authorizations in over 30 countries and to pursue its expansion internationally.
Today, Provepharm has a range of hospital products and is positioned as the leader in dyes in Europe. By working closely with hospital practitioners, Provepharm is also committed to develop specific services to improve clinical practices. To learn more, please visit us on www.provepharm.com/en and follow us on LinkedIn.